Cite
AT1 mutations and risk of atrial fibrillation based on genotypes from 71 000 individuals from the general population.
MLA
Marott, Sarah C. W., et al. “AT1 Mutations and Risk of Atrial Fibrillation Based on Genotypes from 71 000 Individuals from the General Population.” British Journal of Clinical Pharmacology, vol. 76, no. 1, July 2013, pp. 114–24. EBSCOhost, https://doi.org/10.1111/bcp.12050.
APA
Marott, S. C. W., Nordestgaard, B. G., Jensen, G. B., Tybjærg, H. A., & Benn, M. (2013). AT1 mutations and risk of atrial fibrillation based on genotypes from 71 000 individuals from the general population. British Journal of Clinical Pharmacology, 76(1), 114–124. https://doi.org/10.1111/bcp.12050
Chicago
Marott, Sarah C. W., Børge G. Nordestgaard, Gorm B. Jensen, Hansen, Anne Tybjærg, and Marianne Benn. 2013. “AT1 Mutations and Risk of Atrial Fibrillation Based on Genotypes from 71 000 Individuals from the General Population.” British Journal of Clinical Pharmacology 76 (1): 114–24. doi:10.1111/bcp.12050.